Items where Author is "Ninnis, R."

Article

Berneis, K. and Ninnis, R. and Haussinger, D. and Keller, U.. (1999) Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans. American journal of physiology : AJP, Vol. 276, H. 1, Pt. 1 , E188-E195.

Bilz, S. and Ninnis, R. and Keller, U.. (1999) Effects of hypoosmolality on whole-body lipolysis in man. Metabolism, Vol. 48, H. 4. pp. 472-476.

Shalev, A. and Ninnis, R. and Keller, U.. (1998) Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men. Hormone Research, 49 (5). pp. 221-225.

Zulewski, H. and Ninnis, R. and Miserez, A. R. and Baumstark, M. W. and Keller, U.. (1998) VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Journal of Lipid Research, 39, (2). pp. 380-387.

Berneis, K. and Ninnis, R. and Keller, U.. (1997) Ethanol exerts acute protein-sparing effects during postabsorptive but not during anabolic conditions in man. Metabolism, Vol. 46, H. 7. pp. 750-755.

Fried, R. and Beckmann, N. and Keller, U. and Ninnis, R. and Stalder, G. and Seelig, J.. (1996) Early glycogenolysis and late glycogenesis in human liver after intravenous administration of galactose. American journal of physiology. Gastrointestinal and liver physiology, Vol. 270, H. 1 , G14-G19.

Oehri, M. and Ninnis, R. and Girard, J. and Frey, F. J. and Keller, U.. (1996) Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. American journal of physiology : AJP, Vol. 270, H. 4, Pt. 1 , E552-E558.

Laager, R. and Ninnis, R. and Keller, U.. (1993) Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. Journal of Clinical Investigation, Vol. 92, H. 4. pp. 1903-1909.

Turkalj, I. and Keller, U. and Ninnis, R. and Vosmeer, S. and Stauffacher, W.. (1992) Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. Journal of clinical endocrinology and metabolism, Vol. 75, H. 5. pp. 1186-1191.